Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in sickle cell disease
NCT01077921Phase 2Completed
- Start
- Jun 2010
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in sickle cell disease (SCD) comparing Propranolol with Placebo (2 arms). Primary endpoint: Sickle Red Blood Cell Adhesion to Endothelial Cells. Started Jun 2010; status: completed.
02
Drugs
propranolol
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01077921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01077921.